Astellas Pharma uses at least 5 email formats with first.last (ex. John.Smith@astellas.com) being used 68.6% of the time
Get Verified Emails
Astellas Pharma Email Formats | Percentage | |
---|---|---|
first.last | John.Smith@astellas.com | 68.6% |
first.last | John.Smith@us.astellas.com | 15.1% |
first + last | JohnSmith@astellas.com | |
first_last | John_Smith@astellas.com | |
first | John@astellas.com |
Quarter | Revenue |
---|---|
'21 - Q1 | 11546806000 |
'21 - Q2 | 11796370000 |
Dec 08, 2018
Iota Biosciences
Jun 12, 2018
Ogeda
Jul 11, 2014
VESIcare
Dec 07, 2013
Euroscreen
Cadus
Cell Pathways
See More Acquisitions & Subsidiaries
Astellas Pharma’s headquarters are in 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo, Tokyo, Japan
Astellas Pharma’s phone number is +81 3-3244-3000
Astellas Pharma’s stock symbol is 4503
Astellas Pharma’s official website is www.astellas.com
Astellas Pharma’s revenue is $11 Billion
Astellas Pharma’s SIC: 28,283
Astellas Pharma’s NAICS: 62151,42421
Astellas Pharma has 15,455 employees
Astellas Pharma is in the industry of: Manufacturing, Pharmaceuticals, Drug Stores & Pharmacies
Astellas Pharma's main competitors are: LEO Pharma, Shionogi & Co, Takeda, Amneal
Astellas Pharma has acquired the companies: Iota Biosciences, Ogeda, VESIcare, Euroscreen
The technologies that are used by Astellas Pharma are: Microsoft Exchange Server 2010, SAP Warehouse Management, Apollo, Microsoft SQL Server Reporting
Astellas Pharma's CEO is Kenji Yasukawa
Astellas Pharma's CFO is Naoki Okamura